Company research

Explore company profiles, quarterly results, announcements and ownership disclosures.

Loading the company view…

Healthcare Global Enterprises Limited (HCG) — Stock Analysis

Healthcare Global Enterprises Limited (NSE: HCG), ISIN INE075I01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

HCG last traded at ₹587.10 (-2.13%), with a 52-week range of ₹513.30 to ₹775.00 (as of 6 Nov 2026).

Shareholding as of Sep 2026: promoters 64.21%, FIIs 2.70%, DIIs 20.78%, mutual funds 18.73%.

EquiSense Score (ECS): 72/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.